Currently, there are 107.34M common shares owned by the public and among those 104.16M shares have been available to trade.
The company’s stock has a 5-day price change of 10.59% and 45.18% over the past three months. JBL shares are trading 36.82% year to date (YTD), with the 12-month market performance up to 62.58% higher. It has a 12-month low price of $95.85 and touched a high of $182.13 over the same period. JBL has an average intraday trading volume of 1.37 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 13.63%, 25.61%, and 38.79% respectively.
Institutional ownership of Jabil Inc (NYSE: JBL) shares accounts for 97.75% of the company’s 107.34M shares outstanding.
It has a market capitalization of $21.14B and a beta (3y monthly) value of 1.14. The stock’s trailing 12-month PE ratio is 38.28, while the earnings-per-share (ttm) stands at $5.14. The company has a PEG of 2.85 and a Quick Ratio of 0.64 with the debt-to-equity ratio at 2.59. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.45% over the week and 2.22% over the month.
Analysts forecast that Jabil Inc (JBL) will achieve an EPS of 2.84 for the current quarter, 2.41 for the next quarter and 10.5 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 2.7 while analysts give the company a high EPS estimate of 2.7. Comparatively, EPS for the current quarter was 2.3 a year ago. Earnings per share for the fiscal year are expected to increase by 8.33%, and 14.69% over the next financial year. EPS should shrink at an annualized rate of 13.44% over the next five years, compared to 43.90% over the past 5-year period.
Barclays coverage for the Jabil Inc (JBL) stock in a research note released on January 17, 2024 offered a Overweight rating with a price target of $151. Barclays was of a view on September 07, 2023 that the stock is Overweight, while JP Morgan gave the stock Overweight rating on July 05, 2023, issuing a price target of $110. UBS on their part issued Neutral rating on December 13, 2022.
